Showing 15,981 - 16,000 results of 27,040 for search '(( 50 ((mean decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (teer decrease)) ))', query time: 1.11s Refine Results
  1. 15981
  2. 15982
  3. 15983
  4. 15984
  5. 15985
  6. 15986

    Metformin does not further increase the median lifespan of DR-constitutive mutant eat-2, and metformin treatment triggers several DR phenotypes in wild-type <i>C. elegans</i> witho... by Brian Onken (86790)

    Published 2010
    “…<p><b>A.</b> Survival curves of <i>eat-2(ad1116)</i> mutants raised on 0 mM, 1 mM, 10 mM, and 50 mM metformin plates at 20°C. …”
  7. 15987

    Amount and type of maternal dietary fat induced altered Pe-induced vasoconstriction in the offspring. by Christopher J. Kelsall (173702)

    Published 2012
    “…<p>Values are mean ± SD (n = 6/group) concentration which produced 50% maximum response (EC<sub>50</sub>) such that increasing values on the y-axis correspond to decreasing vasoconstriction. …”
  8. 15988
  9. 15989

    Variation of average codeword length (ACL) by number of edges. by Dario Elias (8882177)

    Published 2020
    “…A positive variation indicates a decrease in the ACL. …”
  10. 15990
  11. 15991
  12. 15992

    Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-I<i>α</i> by Lin Li (28817)

    Published 2015
    “…The activation of PKG–1α was then studied using targeted proteomic analysis (MRM-MS) checking the phosphorylation state of the autophosphorylation domain (aa42-94). Significant decrease in phosphorylation of PKG-Iα at Ser50, Ser72, Ser89 was induced by HR injury while SCU treatment significantly increased the phosphorylation of PKG-Iα, not only at Ser50, Ser72 and Ser89, but also at Ser44 and Thr58 (two novel phosphorylation domains). …”
  13. 15993

    Histone deacetylase (HDAC) inhibitor assessment. by Ilona Tkachyova (343715)

    Published 2016
    “…ITF 2357, an HDAC inhibitor which is structurally and functionally similar to SAHA, produced a dose-response curve with IC<sub>50</sub> of 0.2 μM. …”
  14. 15994

    Plk1 inhibition suppresses the clonogenic potential of SUM149 and SUM159. by Antonio Giordano (55096)

    Published 2019
    “…(B) EC<sub>50</sub> was defined as 50% colony inhibition. Single agents EC<sub>50</sub> were reported for each TNBC cell line and drug. …”
  15. 15995

    Regulation of MCF-7 mammosphere formation by breast cancer promoters and metformin. by Ji-Won Jung (194917)

    Published 2011
    “…On the other hand, metformin treatment decreased MCF-7 proliferation (mean ± SD, n = 3). *, <i>P</i><0.05; **, <i>P</i><0.01; ***, <i>P</i><0.001. …”
  16. 15996

    Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  17. 15997

    Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  18. 15998

    Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  19. 15999

    Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”
  20. 16000

    Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

    Published 2024
    “…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”